These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 35416973)
41. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. Tuddenham S; Hamill MM; Ghanem KG JAMA; 2022 Jan; 327(2):161-172. PubMed ID: 35015033 [TBL] [Abstract][Full Text] [Related]
43. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Peterman TA; Tian LH; Metcalf CA; Satterwhite CL; Malotte CK; DeAugustine N; Paul SM; Cross H; Rietmeijer CA; Douglas JM; Ann Intern Med; 2006 Oct; 145(8):564-72. PubMed ID: 17043338 [TBL] [Abstract][Full Text] [Related]
44. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea. Badman SG; Vallely LM; Toliman P; Kariwiga G; Lote B; Pomat W; Holmer C; Guy R; Luchters S; Morgan C; Garland SM; Tabrizi S; Whiley D; Rogerson SJ; Mola G; Wand H; Donovan B; Causer L; Kaldor J; Vallely A BMC Infect Dis; 2016 Jun; 16():250. PubMed ID: 27268218 [TBL] [Abstract][Full Text] [Related]
45. Should expedited partner treatment for women with Trichomonas vaginalis be recommended? Kissinger P Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719 [No Abstract] [Full Text] [Related]
47. Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center. Keating MA; Nyirjesy P Sex Transm Dis; 2015 Sep; 42(9):482-5. PubMed ID: 26267873 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314 [TBL] [Abstract][Full Text] [Related]
49. The clinical spectrum of Trichomonas vaginalis infection and challenges to management. Muzny CA; Schwebke JR Sex Transm Infect; 2013 Sep; 89(6):423-5. PubMed ID: 23543252 [TBL] [Abstract][Full Text] [Related]
50. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women. Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661 [TBL] [Abstract][Full Text] [Related]
51. Offering routine trichomonas vaginalis testing to patients presenting for abortion at an urban hospital-based clinic. Cheeks ML; Schwartz R; Oleson EC; Cohen S; Drey EA; Seidman D Contraception; 2021 Jun; 103(6):423-425. PubMed ID: 33539801 [TBL] [Abstract][Full Text] [Related]
52. Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women. Price CM; Peters RPH; Steyn J; Mudau M; Olivier D; De Vos L; Morikawa E; Kock MM; Medina-Marino A; Klausner JD Sex Transm Dis; 2018 May; 45(5):332-336. PubMed ID: 29465686 [TBL] [Abstract][Full Text] [Related]
53. Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women. Schwebke JR; Gaydos CA; Davis T; Marrazzo J; Furgerson D; Taylor SN; Smith B; Bachmann LH; Ackerman R; Spurrell T; Ferris D; Burnham CA; Reno H; Lebed J; Eisenberg D; Kerndt P; Philip S; Jordan J; Quigley N J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29167292 [TBL] [Abstract][Full Text] [Related]
55. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393 [TBL] [Abstract][Full Text] [Related]
56. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection. Munson E; Kramme T; Napierala M; Munson KL; Miller C; Hryciuk JE J Clin Microbiol; 2012 Dec; 50(12):3927-31. PubMed ID: 23015673 [TBL] [Abstract][Full Text] [Related]
57. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586 [TBL] [Abstract][Full Text] [Related]
58. Detection of metronidazole resistance in Trichomonas vaginalis using uncultured vaginal swabs. Ngobese B; Singh R; Han KSS; Tinarwo P; Mabaso N; Abbai NS Parasitol Res; 2022 Aug; 121(8):2421-2432. PubMed ID: 35657426 [TBL] [Abstract][Full Text] [Related]
59. Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women. Hillier SL Sex Transm Infect; 2013 Sep; 89(6):415. PubMed ID: 23956294 [No Abstract] [Full Text] [Related]
60. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women. Lazenby GB; Thompson L; Powell AM; Soper DE Sex Transm Dis; 2019 Jan; 46(1):2-8. PubMed ID: 30067546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]